Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Felix O. Okunlola"'
Publikováno v:
Cell Biochemistry and Biophysics. 80:495-504
Publikováno v:
Letters in Drug Design & Discovery. 19:379-386
Poly ADP-ribose polymerase-1 (PARP-1), due to its role in DNA damage and repair, has been identified as a crucial therapeutic target to attenuate cancer development and progression. More so, selective inhibition has remained a focal point in PARP-1 t
Publikováno v:
Molecular Simulation. 48:131-139
Poly (ADP-ribose) polymerase (PARP) inhibition by pharmacological agents has been a useful cancer treatment in recent times. PARP inhibitors represent a category of anticancer drugs that function b...
Autor:
Oluwole B. Akawa, Felix O. Okunlola, Mahmoud E. S. Soliman, Temitayo I. Subair, Kehinde F. Omolabi
Publikováno v:
Cell Biochemistry and Biophysics. 80:1-10
In recent years, tankyrase inhibition has gained a great focus as an anti-cancer strategy due to their modulatory effect on WNT/β-catenin pathway implicated in many malignancies, including colorectal cancer (CRC) and non-small cell lung cancer (NSCL
Publikováno v:
The Protein Journal. 40:166-174
Upregulation of Heme Oxygenase-1 (HO-1) has been widely implicated in cancer growth and chemoresistance. This explains the numerous drug discovery efforts aimed at mitigating its pro-carcinogenic roles till date. In a recent study, two selective azol
Autor:
Mahmoud E. Soliman, Adeniyi T. Adewumi, Oluwole B. Akawa, Temitayo I. Subair, Felix O. Okunlola, Oluwayimika E. Akinsuku, Shahzeb Khan
Publikováno v:
AAPS PharmSciTech. 23
Autor:
Chwayita, Mgoboza, Felix O, Okunlola, Oluwole B, Akawa, Aimen, Aljoundi, Mahmoud E S, Soliman
Publikováno v:
Cell biochemistry and biophysics. 80(3)
In recent times, inhibition of poly (ADP-ribose) polymerase (PARP) enzymes by pharmacological drugs has attracted much attention as an anticancer therapy. As reported, PARP-16 has been discovered as a novel anticancer target for small cell lung cance
Autor:
Mahmoud E, Soliman, Adeniyi T, Adewumi, Oluwole B, Akawa, Temitayo I, Subair, Felix O, Okunlola, Oluwayimika E, Akinsuku, Shahzeb, Khan
Publikováno v:
AAPS PharmSciTech. 23(3)
The oral drug bioavailability (BA) problems have remained inevitable over the years, impairing drug efficacy and indirectly leading to eventual human morbidity and mortality. However, some conventional lab-based methods improve drug absorption leadin
Publikováno v:
Journal of biomolecular structuredynamics. 40(21)
PARP-1 has become an attractive target in cancer treatment owing to its significant role in breast and ovarian cancers. The design of highly selective and effective poly (ADP ribose) polymerase-1 inhibitors has significant therapeutic advantages and
Autor:
Felix O, Okunlola, Oluwole B, Akawa, Temitayo I, Subair, Kehinde F, Omolabi, Mahmoud E S, Soliman
Publikováno v:
Cell biochemistry and biophysics. 80(1)
In recent years, tankyrase inhibition has gained a great focus as an anti-cancer strategy due to their modulatory effect on WNT/β-catenin pathway implicated in many malignancies, including colorectal cancer (CRC) and non-small cell lung cancer (NSCL